Stock Analysis of Madrigal Pharmaceuticals Inc (MDGL) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code MDGL
Close 236.16
Change 10.67 / 4.73 %
Volume 348318
Vol Change 113828 / 48.54 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bullish
Growth Index Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Very Low Stability Stock


Fundamental View of Madrigal Pharmaceuticals Inc
PE (TTM)

-2440.93

Very Poor
Price / Book

3539.34

Very Poor
Price / Sales

0

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

5032.92 M

Enterprise Value

5049.02 M

ROA (TTM)

-85.58

Very Poor
ROE (TTM)

-145.00

Very Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

26.50 %

-373630.00 K
Debt to Equity

0.286

Excellent
Altman Z Score

8.93

Excellent
Quick Ratio

0

Poor
Cash Ratio

5.35

Very Good


Highs/Lows of Madrigal Pharmaceuticals Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week229.58 2.87 % 0.513 % 236.72219.3931-May-2429-May-24
Two Week220.06 7.32 % 0.486 % 250.34218.922-May-2420-May-24
One Month204.02 15.75 % 4.80 % 250.34200.0822-May-2409-May-24
Three Month236.2 0.0169 % 3.56 % 299.98189.015-Mar-2426-Apr-24
Six Months203.3 16.16 % 15.54 % 299.98168.24615-Mar-2409-Feb-24
One year278.41 15.18 % 26.26 % 299.98119.7615-Mar-2427-Oct-23
Two year66.39 255.72 % 27.72 % 322.6757.2101-May-2314-Dec-22
Five year92.4 155.58 % 91.77 % 322.6752.3301-May-2328-Jan-22
Ten year143.5 64.57 % 174.36 % 325.985.2506-Jun-1808-Feb-16


Technical View of Madrigal Pharmaceuticals Inc
RSI

57.56

Neutral
MACD

2.01

Bullish
ADX

16.42

Neutral
Super Trend

204.31

Mild Bullish
Williams %R

-31.97

Neutral
CCI

66.97

Neutral


EMA 5

229.51

Strong Bullish
EMA 15

225.76

Neutral
EMA 50

226.37

Whipsaw
EMA 100

224.72

Whipsaw
SMA 100

231.59

Whipsaw
SMA 200

204.19

Mild Bullish
SMA 5 / 20

227.41 / 222.82

Bullish
SMA 15 / 50

223.87 / 228.37

Mild Bearish
SMA 50 / 200

228.37 / 204.19

Mild Bullish




Charts of Madrigal Pharmaceuticals Inc


Returns of Madrigal Pharmaceuticals Inc with Peers
Period / StockMDGLBBIOOPCHGRFS
1 Week2.87%0.251%2.69%-0.556%
1 Mth15.75%9.33%-0.234%11.35%
3 Mth-0.0169%-17.98%-7.59%-4.66%
6mth16.16%-2.44%0.235%-26.11%
1 Year-15.18%104.15%8.24%-13.11%
2 Year255.72%310.10%-1.78%-44.41%
5 Years155.58%-260.14%-59.30%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Madrigal Pharmaceuticals Inc with Peers
Ratio / StockMDGLBBIOOPCHGRFS
PE-2440.93-4217.6419.6220.99
P/B3539.34-2647.803.760.590
ROA-85.58-84.638.441.07
ROE-145.00019.163.89
Debt To Equity0.286-1.280.7601.57
Revenue0
% 		9428.00 K
87.86 % 		4205.15 M
6.60 % 		6535.17 M
7.77 %
Net Income-373630.00 K
26.50 % 		-612645.00 K
27.32 % 		257442 K
70.99 % 		23392.00 K
88.77 %


Technicals of Madrigal Pharmaceuticals Inc with Peers
Technical / StockMDGLBBIOOPCHGRFS-
ADX16.4223.1219.8521.19
CMF-0.04270.076-0.1320.161
MFI64.7933.9522.3572.23
RSI57.5648.3949.1051.22
MACD Abv SignalTrueFalseTrueFalse
Price Above 50 MATrueTrueFalseTrue-
Price Above 200 MATrueFalseFalseFalse-


About : Madrigal Pharmaceuticals Inc

Address : Four Tower Bridge, West Conshohocken, PA, United States, 19428
Tel : 267 824 2827
URL : https://www.madrigalpharma.com
Code : MDGL, ISIN : US5588681057, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 06_Feb_2007
Employee Count : 376

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.


Note : All Data Generated at the End of Trading Hours (EOD Data)